BeOne Medicines
ONC
#692
Rank
A$50.07 B
Marketcap
A$436.00
Share price
-1.81%
Change (1 day)
22.15%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: A$50.07 Billion

As of April 2026 BeOne Medicines has a market cap of A$50.07 Billion. This makes BeOne Medicines the world's 692th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026A$50.07 B-2.97%
2025A$51.61 B56.74%
2024A$32.92 B13.79%
2023A$28.93 B-22.58%
2022A$37.37 B-2.51%
2021A$38.33 B24.54%
2020A$30.78 B110.92%
2019A$14.59 B23.01%
2018A$11.86 B108.11%
2017A$5.70 B241.11%
2016A$1.67 B

End of Day market cap according to different sources

On Apr 20th, 2026 the market cap of BeOne Medicines was reported to be:

A$52.65 Billion
by Nasdaq info icon info icon
A$51.00 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
A$1.30 B-97.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$29.18 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA